Assogna Francesca, Pontieri Francesco E, Caltagirone Carlo, Spalletta Gianfranco
IRCCS Santa Lucia Foundation, Via Ardeatina 306, Rome, Italy.
Eur Neuropsychopharmacol. 2008 Nov;18(11):835-48. doi: 10.1016/j.euroneuro.2008.07.004. Epub 2008 Aug 15.
A limited number of studies in Parkinson's Disease (PD) suggest a disturbance of recognition of facial emotion expressions. In particular, disgust recognition impairment has been reported in unmedicated and medicated PD patients. However, the results are rather inconclusive in the definition of the degree and the selectivity of emotion recognition impairment, and an associated impairment of almost all basic facial emotions in PD is also described. Few studies have investigated the relationship with neuropsychiatric and neuropsychological symptoms with mainly negative results. This inconsistency may be due to many different problems, such as emotion assessment, perception deficit, cognitive impairment, behavioral symptoms, illness severity and antiparkinsonian therapy. Here we review the clinical characteristics and neural structures involved in the recognition of specific facial emotion expressions, and the plausible role of dopamine transmission and dopamine replacement therapy in these processes. It is clear that future studies should be directed to clarify all these issues.
帕金森病(PD)的少数研究表明面部情绪表达识别存在障碍。特别是,在未用药和用药的PD患者中均报告有厌恶识别受损。然而,在情绪识别障碍的程度和选择性定义方面,结果相当不确定,并且还描述了PD中几乎所有基本面部情绪的相关障碍。很少有研究调查与神经精神和神经心理症状的关系,主要结果为阴性。这种不一致可能是由于许多不同的问题,如情绪评估、感知缺陷、认知障碍、行为症状、疾病严重程度和抗帕金森治疗。在此,我们综述了识别特定面部情绪表达所涉及的临床特征和神经结构,以及多巴胺传递和多巴胺替代疗法在这些过程中可能发挥的作用。显然,未来的研究应致力于阐明所有这些问题。